An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...
BioCina, a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dr. Thomas Broudy has been appointed as Chief Executive Officer to lead the company's ...
A new way to deliver protective antibodies against COVID-19 was tested in a Phase I clinical trial. Instead of injecting ...